D. Hreniuk

发表

A Receptor in Pituitary and Hypothalamus That Functions in Growth Hormone Release

Patrick R. Griffin, Arthur A. Patchett, Alex Elbrecht, 1996, Science.

Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a.

M. Bednarek, L. V. D. van der Ploeg, A. Howard, 2000, Journal of medicinal chemistry.

Melanin-concentrating hormone receptor subtypes 1 and 2: species-specific gene expression.

C. Austin, D. Macneil, H. Iwaasa, 2002, Genomics.

Synthesis and biological evaluation in vitro of selective, high affinity peptide antagonists of human melanin-concentrating hormone action at human melanin-concentrating hormone receptor 1.

M. Bednarek, D. Macneil, L. V. D. van der Ploeg, 2002, Biochemistry.

Heterocyclic acetamide and benzamide derivatives as potent and selective beta3-adrenergic receptor agonists with improved rodent pharmacokinetic profiles.

M. Struthers, R. Berger, S. Feighner, 2010, Bioorganic & medicinal chemistry letters.

Increased melanin concentrating hormone receptor type I in the human hypothalamic infundibular nucleus in cachexia.

D. Swaab, D. Macneil, L. V. D. van der Ploeg, 2005, The Journal of clinical endocrinology and metabolism.

Characterization of the bombesin-like peptide receptor family in primates.

M. Reitman, H. Iwaasa, A. Sailer, 2004, Genomics.

Partial agonists and full antagonists at the human and murine bradykinin B1 receptors.

J. Hess, L. V. D. van der Ploeg, S. Feighner, 1997, Canadian journal of physiology and pharmacology.

Molecular Characterization and Expression of Cloned Human Galanin Receptors GALR2 and GALR3

L. F. Kolakowski, B. O'dowd, S. Kargman, 1998, Journal of neurochemistry.

Discovery and optimization of novel 4-[(aminocarbonyl)amino]-N-[4-(2-aminoethyl)phenyl]benzenesulfonamide ghrelin receptor antagonists.

M. Tota, A. Howard, S. Feighner, 2009, Bioorganic & medicinal chemistry letters.

Structural Requirements for the Activation of the Human Growth Hormone Secretagogue Receptor by Peptide and Nonpeptide Secretagogues

D. Underwood, Roy G. Smith, J. Woods, 1997 .

Synthesis and Biological Evaluation in Vitro of a Selective, High Potency Peptide Agonist of Human Melanin-concentrating Hormone Action at Human Melanin-concentrating Hormone Receptor 1*

M. Bednarek, D. Macneil, L. V. D. van der Ploeg, 2002, The Journal of Biological Chemistry.

Structural requirements for the activation of the human growth hormone secretagogue receptor by peptide and nonpeptide secretagogues.

D. Underwood, L. V. D. van der Ploeg, J. Woods, 1998, Molecular endocrinology.

Spiro(indoline-3,4'-piperidine) growth hormone secretagogues as ghrelin mimetics.

L. V. D. van der Ploeg, A. Howard, S. Feighner, 2001, Bioorganic & medicinal chemistry letters.

Molecular analysis of a new splice variant of the human melanocortin‐1 receptor

D. Macneil, L. V. D. van der Ploeg, A. Howard, 1999, FEBS letters.

Detection of intracellular calcium elevations in Xenopus laevis oocytes: aequorin luminescence versus electrophysiology

E. H. Rydberg, S. Feighner, J. P. Arena, 1996, Journal of Neuroscience Methods.

Molecular analysis of rat pituitary and hypothalamic growth hormone secretagogue receptors.

M. Phillips, Roy G. Smith, L. V. D. van der Ploeg, 1997, Molecular endocrinology.

Identification and characterization of a second melanin-concentrating hormone receptor, MCH-2R

Christopher P. Austin, Masahiko Ito, Alka Bansal, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Identification of receptors for neuromedin U and its role in feeding

Christopher P. Austin, Jilly F. Evans, C. Thomas Caskey, 2000, Nature.

Receptor for motilin identified in the human gastrointestinal system.

Jilly F. Evans, Ploeg, C. Austin, 1999, Science.

Ligand activation domain of human orphan growth hormone (GH) secretagogue receptor (GHS-R) conserved from Pufferfish to humans.

A. Howard, S. Feighner, D. Hreniuk, 2000, Molecular endocrinology.

Design of a novel pyrrolidine scaffold utilized in the discovery of potent and selective human β3 adrenergic receptor agonists.

M. Struthers, S. Galloway, S. Feighner, 2011, Bioorganic & medicinal chemistry letters.

4-Aminoquinoline melanin-concentrating hormone 1-receptor (MCH1R) antagonists.

N. Morin, D. Macneil, R. DeVita, 2006, Bioorganic & medicinal chemistry letters.

2-Aminoquinoline melanin-concentrating hormone (MCH)1R antagonists.

Ramon Camacho, D. Macneil, R. DeVita, 2006, Bioorganic & medicinal chemistry letters.

Chronic MCH-1 receptor modulation alters appetite, body weight and adiposity in rats.

M. Bednarek, D. Macintyre, Dan Zhou, 2003, European journal of pharmacology.

Molecular Analysis of the Growth Hormone Secretagogue Receptor

Roy G. Smith, A. Howard, S. Feighner, 1999 .

Growth Hormone Releasing Substances: Types and Their Receptors

A. Howard, S. Feighner, D. Hreniuk, 1999, Hormone Research in Paediatrics.

Cloning and characterization of two human G protein-coupled receptor genes (GPR38 and GPR39) related to the growth hormone secretagogue and neurotensin receptors.

Roy G. Smith, L. V. D. van der Ploeg, A. Howard, 1997, Genomics.

Cloning and characterization of a human and murine T-cell orphan G-protein-coupled receptor similar to the growth hormone secretagogue and neurotensin receptors.

A. Howard, S. Feighner, D. Hreniuk, 1998, Genomics.

Mutations in murine Mx1: effects on localization and antiviral activity.

L. V. D. van der Ploeg, D. Hreniuk, E. Garber, 1993, Virology.

Short segment of human melanin-concentrating hormone that is sufficient for full activation of human melanin-concentrating hormone receptors 1 and 2.

D. Macneil, S. Feighner, D. Hreniuk, 2001, Biochemistry.